Hodgkin disease in children: Clinicoepidemiologic and vital (Epstein- Barr virus) analyses

Medical and Pediatric Oncology

Volumn 32, Issue 1, 1999, Pages 18-24

  Cavdar A O ^a   Pamir, A ^a   Gozdasoglu S ^a   Babacan, E ^a   Yavuz, G ^a   Unal E ^a   Uluoglu, Ö ^b   Tacyildiz N ^a   Ikinciogullari A ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; VIRUS CAPSID ANTIGEN;

ADOLESCENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CHILD; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOFLUORESCENCE; INFANT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; SOCIOECONOMICS;

ADOLESCENT; AGE FACTORS; ANTIGENS, VIRAL; CAPSID; CAPSID PROTEINS; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; MALE; NEOPLASM STAGING; ONCOGENE PROTEINS, VIRAL; RETROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; TRACE ELEMENTS; TUMOR VIRUS INFECTIONS; TURKEY; VIRAL MATRIX PROTEINS;

EID: 0032930852     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199901)32:1<18::AID-MPO5>3.3.CO;2-J     Document Type: Article

References (43)

1. Gutenshon N, Cole P. Childhood social environment and Hodgkin's disease. N Engl J Med 1981;304:135-140.
2. Correa P, O'Connor GT. Epidemiologic pattern of Hodgkin's disease. Int J Cancer 1971;8:192-201.
3. Rosenthal J, Weyl Ben Arush M, Kuten A, et al. Hodgkin's disease in childhood: Treatment modalities, outcome and epidemiological aspects. Am J Pediatr Hematol/Oncol 1994;16:138-142.
4. Çavdar AO, Taçoy A, Babacan E, et al. Hodgkin's disease in Turkish children. A clinical and histopathologic analysis. J Natl Cancer Inst 1977;58:479-481.
5. Olweny CL, Katangale-Mbide E, Kiire C, et al. Childhood Hodgkin's disease in Uganda. Cancer 1978;42:787-792.
6. Mockonko K, Fejes M, Breazavscak DM, et al. The relation between EBV antibodies and clinical symptomatology and immune deficiency in patients with Hodgkin's disease. Cancer 1979;44: 2065-2070.
7. Rockford R, Mosier DE. Immunobiology of Epstein-Barr virus associated lymphomas. Clin Immunol Immunopathol 1994;71: 256-262.
8. 2 negative phenotype. Cancer 1994;73:3059-3063.
9. Osorno AZ, Roman LN, Kingina DW, et al. Hodgkin's disease in Mexico. Cancer 1995;75:1360-1366.
10. Tomito Y, Ohsawa M, Manno H, et al. Epstein-Barr virus in Hodgkin's disease patients in Japan. Cancer 1996;77:186-192.
11. Preciado MV, Matteo ED, Diaz B, et al. EBV latent membrane protein (LMP) in tumor cells of Hodgkin's disease in pediatric patients. Med Pediatr Oncol 1995;24:1-5.
12. Zhou XG, Hamilton-Dutoit SJ, Van QH, et al. The association between EBV and Chinese Hodgkin's disease. Int J Cancer 1993; 55:359-363.
13. Chang K, Albujar P, Chen I, et al. High prevalence of Epstein-Barr virus in the Reed Sternberg cell of Hodgkin's disease occurring in Peru. Blood 1993;81:496-501.
14. Ambinder RN, Browning P, Lorengana I, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993;81:462-467.
15. Armstrong AA, Abwander FE, Faes RP, et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993;142:1683-1688.
16. Brousset P, Rochaix P, Chittal S, et al. High incidence of EBV detection in Hodgkin's disease and absence of detection in anaplastic large cell lymphoma in children. Histopathology 1993;23: 189-194.
17. Kaczorowski S, Kaczorowska M, Christensson B. Expression of EBV encoded latent membrane protein (LMP-1) and Bel-2 protein in childhood and adult Hodgkin's disease: Application of microwave irradiation for antigen retrieval. Leuk Lymphoma 1994;13: 273-283.
18. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: Epidemiological characteristics in international data. Int J Cancer 1997;70:375-382.
19. Razzouk BI, Gan YJ, Mendonça C, et al. Epstein-Barr virus in pediatric Hodgkin's disease: Age and histiotype are more predictive than geographic region. Med Pediatr Oncol 1997;28:248-254.
20. Çavdar AO, Yavuz G, Babacan E, et al. Burkitt's lymphoma in Turkish children: Clinical, viral (EBV) and molecular studies. Leuk Lymphoma 1994;14:323-330.
21. Hudson MM, Donaldson SS. Hodgkin's disease. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-Raven, 3rd ed.; 1997. p 523-544.
22. Çavdar AO, Babacan E, Gözdaşoǧlu S, et al. Zinc and anergy in pediatric Hodgkin's disease in Turkey. Cancer 1987;59:305-309.
23. Pamir A, Çavdar AO, Vonlanthen R, et al. Epstein-Barr virus latent membrane protein expression and distribution of viral subtypes in Turkish Hodgkin's disease (A comparative study with nonneoplastic lymphoid hyperplasia). Med Pediatr Oncol 1995; 25:260.
24. Pamir A, Vonlanthen R, Tinguely M, Borisch B. Epstein-Barr virus in Hodgkin's disease in a Turkish population: Prevalence of viral subtypes and correlation with non-neoplastic lymphoid disorders (Submitted).
25. Agresti A, editor. Categorical data analysis. New York: Wiley; 1990.
26. Ramot B, Magrath I. Hypothesis: The environment is a major determinant of the immunological subtype of lymphoma and acute lymphoblastic leukemia in children. Br J Hematol 1982;52:183-189.
27. Sullivan MP, Fuller LM, Butler JJ. In: Sutow WW, Vietti TJ, editors. Chapter 19: Hodgkin's disease in Children in Clinical Pediatric Oncology. St. Louis: Mosby; 1977. p 408-443.
28. Colonna P, Merzong KB, Henni T, et al. Changes in patterns of Hodgkin's disease in Algeria, 1966-1985: Influence of the health care delivery system. Acta Hematol 1988;80:227-228.
29. Matowy MS, Omar YT. Hodgkin's disease in children in Kuwait. Cancer 1986;57:2255-2259.
30. Gad-El-Mawla N, El-Deeb BB, Abu-Gabal A, et al. Pediatric Hodgkin's disease in Egypt. Cancer 1983;52:1129-1131.
31. Okpala IE, Akang EE, Okpala UZ. Lymphomas in University College Hospital Ibadan, Nigeria. Cancer 1991;68:1356-1360.
32. Alelough M, Vossouah P. Hodgkin's disease in Iranian children. Eur J Pediatr 1993;152:21-31.
33. Çevik N. Pediatric Hodgkin's disease in Türkiye. Eur School Oncol 1993;1-23.
34. Çavdar AO, Gözdaşoǧlu S, Babacan E, et al. Hodgkin's disease in Turkish children. XIIIth Meeting of the International Society of Haematology, Istanbul, Meta, 1995;127-133.
35. Hodgkin's Symposium (in Turkish), Congress Book (13-15 November 1996) Cerrahpaşa İstanbul, Turkey.
36. Ertem U, Duru F, Daǧdemir A, et al. Hodgkin's disease in 82 Turkish children diagnosed over a 10-year period: Epidemiological, clinical and histopathologic features and prognosis with prolonged chemotherapy. Pediatr Hematol Oncol 1997;14:359-366.
37. Chandra RK. Nutrition and immune responses. Can J Physiol Pharmacol 1983;61:292-295.
38. Good RA, Lorenz E. Nutrition and cellular immunity. Int J Immuno Pharmacol 1992;14:361-366.
39. Khan G, Norton A, Slavin G. Epstein-Barr virus in Hodgkin's disease. Cancer 1993;71:3124-3129.
40. Purtilo DT. Epstein-Barr virus induced oncogenesis in immune deficient individuals. Lancet 1980;1:300-304.
41. Ünal E, Çavdar AO, Babacan E, et al. Serum soluble interleukin-2 receptor levels in children with malignant lymphoma. Med Pediatr Oncol 1994;23:276.
42. Babacan E, İkincioǧullari A, Kansu A, et al. Peripheral blood T lymphocyte subsets and natural killer (NK) cells in pediatric Hodgkin's disease (HD) in Turkish children. Med Pediatr Oncol 1993;21:578.
43. Pui CH, Ip SH, Thompson E, et al. High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease. Leukemia 1989;7:481-486.